Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$254M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$158M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$155M |
| 4 |
Intercontinental Exchange
ICE
|
+$116M |
| 5 |
Estee Lauder
EL
|
+$99.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$450M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$184M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$130M |
| 4 |
Hewlett Packard
HPE
|
+$119M |
| 5 |
GE Aerospace
GE
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Technology | 14.17% |
| 3 | Healthcare | 13.27% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4126
Protalix BioTherapeutics
PLX
$210M
| $25K | ﹤0.01% |
2,978
| – | – |
2013 Q2
16 quarters
|
|
|
CFRX
4127
DELISTED
ContraFect Corporation
CFRX
| $25K | ﹤0.01% |
22
| – | – |
2017 Q1
1 quarter
|
|
|
XPLR
4128
DELISTED
Xplore Technologies Corp.
XPLR
| $24K | ﹤0.01% |
12,371
| – | – |
2017 Q1
1 quarter
|
|
4129
Ideal Power
IPWR
$52.8M
| $23K | ﹤0.01% |
1,072
| – | – |
2016 Q4
2 quarters
|
|
4130
iShares National Muni Bond ETF
MUB
$49.2B
| $23K | ﹤0.01% |
20,537
+3,654
| +22% | +$402K |
2013 Q2
16 quarters
|
|
4131
SELLAS Life Sciences
SLS
$2.29B
| $23K | ﹤0.01% |
27
-59
| -69% | -$51.3K |
2016 Q4
2 quarters
|
|
|
BIOC
4132
DELISTED
Biocept, Inc.
BIOC
| $23K | ﹤0.01% |
2
| – | – |
2017 Q1
1 quarter
|
|
|
UWN
4133
DELISTED
Nevada Gold & Casinos, Ltd.
UWN
| $23K | ﹤0.01% |
10,369
-4,441
| -30% | -$10.2K |
2017 Q1
1 quarter
|
|
|
RTK
4134
DELISTED
Rentech, Inc.
RTK
| $23K | ﹤0.01% |
48,776
-569
| -1% | -$252 |
2013 Q2
16 quarters
|
|
|
VSR
4135
DELISTED
Versar, Inc.
VSR
| $23K | ﹤0.01% |
15,336
| – | – |
2013 Q2
16 quarters
|
|
|
FSNN
4136
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
| $22K | ﹤0.01% |
10,245
| – | – |
2017 Q1
1 quarter
|
|
4137
Alphatec Holdings
ATEC
$1.69B
| $21K | ﹤0.01% |
11,250
+246
| +2% | +$497 |
2017 Q1
1 quarter
|
|
4138
Bloomia Holdings
TULP
$10.2M
| $21K | ﹤0.01% |
2,942
| – | – |
2013 Q2
16 quarters
|
|
4139
Microbot Medical
MBOT
$63.8M
| $21K | ﹤0.01% |
997
| – | – |
2017 Q1
1 quarter
|
|
4140
Moleculin Biotech
MBRX
$7.54M
| $21K | ﹤0.01% |
5
| – | – |
2017 Q1
1 quarter
|
|
4141
Paramount Gold Nevada
PZG
$91.4M
| $21K | ﹤0.01% |
13,808
| – | – |
2013 Q2
16 quarters
|
|
4142
Protara Therapeutics
TARA
$147M
| $21K | ﹤0.01% |
352
| – | – |
2015 Q2
8 quarters
|
|
4143
United States Antimony
UAMY
$416M
| $20K | ﹤0.01% |
51,398
-1,641
| -3% | -$689 |
2013 Q2
16 quarters
|
|
4144
VistaGen Therapeutics
VTGN
$9.45M
| $20K | ﹤0.01% |
364
| – | – |
2017 Q1
1 quarter
|
|
4145
Abundia Global Impact Group
AGIG
$37.5M
| $19K | ﹤0.01% |
198
| – | – |
2013 Q2
16 quarters
|
|
4146
DELISTED
SunLink Health Systems
SSY
| $19K | ﹤0.01% |
11,695
| – | – |
2017 Q1
1 quarter
|
|
4147
DELISTED
Astria Therapeutics
ATXS
| $18K | ﹤0.01% |
210
| – | – |
2017 Q1
1 quarter
|
|
4148
Viking Therapeutics
VKTX
$3.48B
| $18K | ﹤0.01% |
16,962
| – | – |
2016 Q2
4 quarters
|
|
4149
Turtle Beach Corp
TBCH
$290M
| $18K | ﹤0.01% |
6,327
| – | – |
2013 Q2
16 quarters
|
|
|
OCRX
4150
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $18K | ﹤0.01% |
15,883
| – | – |
2015 Q3
7 quarters
|
|
Similar funds
Northern Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Northern Trust held 4,391 positions worth $358B, up 3.1% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Northern Trust's Q2 2017 filing shows 142 new, 2,528 increased, 1,287 reduced and 114 closed positions. Its largest new stake was DXC Technology: 3,833,711 shares worth $254M. The largest sale was Yahoo Inc, an estimated $450M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q2 2017 buy was DXC Technology: 3,833,711 shares worth $254M.
- Northern Trust added most to Vanguard FTSE All-World ex-US ETF in Q2 2017, an estimated $158M increase.
- Northern Trust's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $119M.
- Northern Trust fully exited Yahoo Inc in Q2 2017, selling an estimated $450M.
- Northern Trust's ten largest holdings make up 14% of its $358B portfolio in Q2 2017.
- Northern Trust opened 142 new positions and closed 114 in Q2 2017.
- Northern Trust's portfolio value rose 3.1% quarter-over-quarter to $358B.
Based on Northern Trust's 13F filing for Q2 2017, filed 11 Aug 2017.